Arrhythmia Research Technology (HRT) Reports Q2 EPS of $0.02
Tweet
Share
E-mailGet Alerts HRT Hot Sheet
Price: $14.25 --0%
EPS Growth %: +16.7%
Financial Fact:
Selling and marketing: 303.28K
Today's EPS Names:
MAXN, CSTR, ACU, More
EPS Growth %: +16.7%
Financial Fact:
Selling and marketing: 303.28K
Today's EPS Names:
MAXN, CSTR, ACU, More
Join SI Premium – FREE
Arrhythmia Research Technology (NYSE: HRT) reported Q2 EPS of $0.02, versus $0.04 reported last year. Revenue for the quarter came in at $5.13 million, versus $5.66 million reported last year.
For earnings history and earnings-related data on Arrhythmia Research Technology (HRT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Growth isn't weak enough to truly undercut inflation pressures - BMO
- Safe & Green (SGBX) Provides Update on Audit and Planned 10-K Filing
- Schlumberger Ltd. (SLB) Reports In-Line Q1 EPS
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
